Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Palatin Technologies Inc. | 0 | 4 | 0 | 0 | €1.65 | - | - |
| Novan Inc | 0 | 23 | 0 | 0 | €0.001 | - | - |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 0 | 1 | 0 | 0 | €2.17 | - | - |
| Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €1.07 | €2.00 | 87.617% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.37 | €3.00 | 716.549% |
| Fibrogen Inc. | 1 | 2 | 1 | 0 | €1.15 | €4.00 | 249.040% |
| Cara Therapeutics Inc. | 11 | 4 | 0 | 2 | €0.36 | €4.62 | 1199.494% |
| Avinger Inc. | 2 | 4 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Cardiff Oncology Inc. | 2 | 4 | 0 | 0 | €2.18 | €5.00 | 129.358% |
| Gritstone Oncology Inc | 4 | 2 | 0 | 0 | €0.64 | €5.07 | 696.619% |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.82 | €5.51 | 573.333% |
| Inventiva SA | 1 | 1 | 0 | 1 | €2.18 | €6.00 | 175.229% |
| Trevena Inc. | 2 | 19 | 0 | 1 | €0.18 | €6.48 | 3541.573% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €1.19 | €6.49 | 446.608% |
| Bayer AG ADR | 1 | 1 | 0 | 0 | €6.65 | €7.00 | 5.263% |
| Glycomimetics Inc. | 5 | 3 | 0 | 1 | €0.21 | €7.35 | 3409.117% |
| Orasure Tech | 3 | 1 | 0 | 0 | €3.98 | €8.36 | 110.008% |
| AEterna Zentaris Inc. | 2 | 20 | 0 | 1 | €1.87 | €8.51 | 355.096% |
| Evotec SE | 4 | 3 | 2 | 2 | €8.79 | €10.00 | 13.766% |
| Cellectar BioSciences Inc. | 8 | 7 | 3 | 1 | €2.18 | €10.55 | 383.752% |
| Inotiv Inc. | 3 | 1 | 0 | 0 | €1.89 | €10.66 | 464.111% |
| Uniqure B.V. | 1 | 2 | 1 | 2 | €7.86 | €11.00 | 40.020% |
| Cyclacel Pharmaceuticals Inc. | 2 | 10 | 0 | 0 | €0.22 | €14.66 | 6565.591% |
| Elanco Animal Health Inc. | 8 | 3 | 1 | 0 | €11.81 | €15.66 | 32.640% |
| Moleculin Biotech Inc | 3 | 23 | 0 | 2 | €0.41 | €18.42 | 4393.659% |